Fabros, Loreta .

HRN: 23-01-67  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2023
MUPIROCIN 2%, 15G (TUBE)
05/20/2023
05/27/2023
APPLY ON SKIN
As Required
BID
Empiric
Waiting Final Action 
06/01/2023
CEFTAZIDIME 1GM (VIAL)
06/01/2023
06/07/2023
IV
1gm
Q8
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: